Nicotine Addiction Treatment Strategies

First-Line Pharmacotherapy Options

Combination NRT (patch plus fast-acting form like gum, lozenge, or nasal spray) is superior to single-agent therapy, achieving 36.5% abstinence at 6 months versus 23.4% for patch alone (RR 1.25, 95% CI 1.15-1.36), as recommended by the Mayo Clinic 1, 2
Bupropion SR achieves 24.2% abstinence at 6 months (OR 2.0 vs placebo) and can be combined with nicotine patch for patients failing monotherapy, according to the Mayo Clinic Proceedings 1

Brief counseling (≥10 minutes) significantly enhances outcomes when combined with medication, as stated by the Mayo Clinic Proceedings 4, 5
The American Academy of Pediatrics recommends starting NRT 2 weeks before the quit date while still smoking, which doubles abstinence rates at 6 weeks and 6 months (OR 2.20, 95% CI 1.39-3.48) 6, 7

Switching to combination NRT (if not already using) nearly doubles cessation odds (OR 2.73 vs placebo), as suggested by the Praxis Medical Insights 3
The Mayo Clinic Proceedings recommends switching to varenicline if NRT was used initially (or vice versa) 4, 5

NRT is safe even in patients with cardiovascular disease—blood nicotine levels from NRT remain significantly lower than from smoking, according to the Praxis Medical Insights 2, 3
Common side effects include local skin reactions (patches), nausea, mood changes, and sleep disturbances, which are typically dose-dependent, as reported by the Mayo Clinic Proceedings 1, 8

Premature discontinuation before 12 weeks is the most common reason for treatment failure, as noted by the Praxis Medical Insights 2, 3
Using single-agent NRT when combination therapy is indicated—combination therapy is first-line, not a rescue strategy, according to the Praxis Medical Insights 2, 3
Inadequate dosing—ensure sufficient nicotine replacement to control withdrawal symptoms, as recommended by the Praxis Medical Insights 3
Not arranging structured follow-up within 2 weeks of treatment initiation, as suggested by the Praxis Medical Insights 2, 3